Amy B. Levine

1.5k total citations
37 papers, 1.1k citations indexed

About

Amy B. Levine is a scholar working on Surgery, Public Health, Environmental and Occupational Health and Obstetrics and Gynecology. According to data from OpenAlex, Amy B. Levine has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 8 papers in Public Health, Environmental and Occupational Health and 7 papers in Obstetrics and Gynecology. Recurrent topics in Amy B. Levine's work include Gastrointestinal motility and disorders (6 papers), Estrogen and related hormone effects (6 papers) and Gastroesophageal reflux and treatments (5 papers). Amy B. Levine is often cited by papers focused on Gastrointestinal motility and disorders (6 papers), Estrogen and related hormone effects (6 papers) and Gastroesophageal reflux and treatments (5 papers). Amy B. Levine collaborates with scholars based in United States, Belgium and United Kingdom. Amy B. Levine's co-authors include Arkadi Chines, Kathleen Kuhlman, Joseph Bonn, Ginger D. Constantine, Claus Christiansen, René Kerstens, Tobie J. de Villiers, Wulf H. Utian, David F. Archer and JoAnn V. Pinkerton and has published in prestigious journals such as Gastroenterology, American Journal of Obstetrics and Gynecology and Journal of Bone and Mineral Research.

In The Last Decade

Amy B. Levine

36 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy B. Levine United States 16 360 262 249 218 206 37 1.1k
Lone Tjellesen Denmark 21 202 0.6× 229 0.9× 317 1.3× 114 0.5× 35 0.2× 46 1.2k
Elizabeth Ramos‐Lopez Germany 20 547 1.5× 166 0.6× 75 0.3× 68 0.3× 19 0.1× 30 1.6k
Seppo Kivinen Finland 21 285 0.8× 153 0.6× 83 0.3× 134 0.6× 6 0.0× 65 1.1k
Michael Whitaker United States 14 216 0.6× 187 0.7× 243 1.0× 259 1.2× 9 0.0× 36 1.1k
Dietrich Michalk Germany 21 83 0.2× 168 0.6× 123 0.5× 52 0.2× 14 0.1× 65 1.1k
Jean‐Benoît Rossel Switzerland 12 239 0.7× 203 0.8× 22 0.1× 34 0.2× 60 0.3× 61 564
Jesper Rye Andersen Denmark 10 128 0.4× 206 0.8× 17 0.1× 42 0.2× 38 0.2× 22 647
Henry Fehrenbach Germany 16 276 0.8× 101 0.4× 73 0.3× 156 0.7× 5 0.0× 21 1.1k
Hülya Ilıksu Gözü Türkiye 16 73 0.2× 173 0.7× 30 0.1× 89 0.4× 14 0.1× 41 929
G Giuffrida Italy 21 94 0.3× 250 1.0× 19 0.1× 102 0.5× 27 0.1× 65 1.2k

Countries citing papers authored by Amy B. Levine

Since Specialization
Citations

This map shows the geographic impact of Amy B. Levine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy B. Levine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy B. Levine more than expected).

Fields of papers citing papers by Amy B. Levine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy B. Levine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy B. Levine. The network helps show where Amy B. Levine may publish in the future.

Co-authorship network of co-authors of Amy B. Levine

This figure shows the co-authorship network connecting the top 25 collaborators of Amy B. Levine. A scholar is included among the top collaborators of Amy B. Levine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy B. Levine. Amy B. Levine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Camilleri, Michael, Hubert Piessevaux, Yan Yiannakou, et al.. (2016). Efficacy and Safety of Prucalopride in Chronic Constipation: An Integrated Analysis of Six Randomized, Controlled Clinical Trials. Digestive Diseases and Sciences. 61(8). 2357–2372. 63 indexed citations
2.
Benninga, Marc A., et al.. (2016). Development of a population pharmacokinetic model of prucalopride in children with functional constipation. Pharmacology Research & Perspectives. 4(4). e00236–e00236. 7 indexed citations
3.
Palacios, Santiago, Stuart L. Silverman, Tobie J. de Villiers, et al.. (2015). A 7-year randomized, placebo-controlled trial assessing the long-term efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis. Menopause The Journal of The North American Menopause Society. 22(8). 806–813. 63 indexed citations
4.
Beck, Thomas, Thomas Fuerst, Santosh Sutradhar, et al.. (2015). The effects of bazedoxifene on bone structural strength evaluated by hip structure analysis. Bone. 77. 115–119. 9 indexed citations
5.
Yiannakou, Yan, Hubert Piessevaux, Michel Bouchoucha, et al.. (2015). A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial to Evaluate the Efficacy, Safety, and Tolerability of Prucalopride in Men With Chronic Constipation. The American Journal of Gastroenterology. 110(5). 741–748. 72 indexed citations
6.
Mugie, Suzanne M., Bartosz Korczowski, Alexandra Green, et al.. (2014). Prucalopride Is No More Effective Than Placebo for Children With Functional Constipation. Gastroenterology. 147(6). 1285–1295.e1. 76 indexed citations
7.
Palacios, Santiago, Tobie J. de Villiers, Fiorenzo De Cicco Nardone, et al.. (2013). Assessment of the safety of long-term bazedoxifene treatment on the reproductive tract in postmenopausal women with osteoporosis: Results of a 7-year, randomized, placebo-controlled, phase 3 study. Maturitas. 76(1). 81–87. 42 indexed citations
8.
Christiansen, Claus, Charles H. Chesnut, Jonathan D. Adachi, et al.. (2010). Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled phase 3 study of postmenopausal women with osteoporosis. BMC Musculoskeletal Disorders. 11(1). 130–130. 71 indexed citations
9.
Pinkerton, JoAnn V., David F. Archer, Wulf H. Utian, et al.. (2009). Bazedoxifene effects on the reproductive tract in postmenopausal women at risk for osteoporosis. Menopause The Journal of The North American Menopause Society. 16(6). 1102–1108. 65 indexed citations
10.
Aaron, Erika, et al.. (2009). Using the Rapid HIV Test to Rescreen Women in the Third Trimester of Pregnancy. Journal of Midwifery & Women s Health. 54(6). 492–496. 5 indexed citations
11.
Archer, David F., JoAnn V. Pinkerton, Wulf H. Utian, et al.. (2009). Bazedoxifene, a selective estrogen receptor modulator. Menopause The Journal of The North American Menopause Society. 16(6). 1109–1115. 92 indexed citations
12.
Miller, Paul D., Arkadi Chines, Claus Christiansen, et al.. (2007). Effects of Bazedoxifene on BMD and Bone Turnover in Postmenopausal Women: 2-Yr Results of a Randomized, Double-Blind, Placebo-, and Active-Controlled Study. Journal of Bone and Mineral Research. 23(4). 525–535. 184 indexed citations
13.
Worthington, Patricia, et al.. (2000). Invited Review: Nutritional Management of Hyperemesis Gravidarum. Nutrition in Clinical Practice. 15(2). 65–76. 4 indexed citations
14.
Levine, Amy B., Kathleen Kuhlman, & Joseph Bonn. (1999). Placenta accreta: Comparison of cases managed with and without pelvic artery balloon catheters. The Journal of Maternal-Fetal Medicine. 8(4). 173–176. 107 indexed citations
15.
Levine, Amy B., et al.. (1999). Pregnancy outcome in patients requiring parenteral nutrition. The Journal of Maternal-Fetal Medicine. 8(4). 164–167. 39 indexed citations
16.
Levine, Amy B., et al.. (1996). Evaluation of the prethrombotic statein pregnancy and in women using oral contraceptives. Contraception. 53(5). 255–257. 7 indexed citations
17.
Davis, Bárbara, Sara Sullivan, Amy B. Levine, & John Dallara. (1995). Factors affecting ED length-of-stay in surgical critical care patients. The American Journal of Emergency Medicine. 13(5). 495–500. 39 indexed citations
18.
Levine, Amy B., Keith Eddleman, Usha Chitkara, et al.. (1991). Congenital myotonic dystrophy: An often unsuspected cause of severe polyhydramnios. Prenatal Diagnosis. 11(2). 111–115. 4 indexed citations
19.
Seltzer, Vicki, et al.. (1990). Adenofibroma of the uterus: Multiple recurrences following wide local excision. Gynecologic Oncology. 37(3). 427–431. 18 indexed citations
20.
Levine, Amy B., Fred Benjamin, Stanley Deutsch, & Vicki Seltzer. (1988). Comparison of the adrenocorticotropic hormone stimulation test with and without prior dexamethasone suppression in the diagnosis of congenital adrenal hyperplasia. Fertility and Sterility. 50(1). 170–172. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026